Combination Olaparib and Temozolomide in Relapsed Small Cell Lung Cancer: Updated Results from Phase 1/2 Clinical Trial

被引：1
|
作者：
Farago, A. [1 ]
Yeap, B. [1 ]
Heist, R. [1 ]
Marcoux, J. P. [2 ]
Rangachari, D. [3 ]
Barbie, D. [2 ]
Kennedy, E. [2 ]
Mino-Kenudson, M. [4 ]
Shaw, A. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Massachusetts Gen Hosp, Pathol, Boston, MA 02114 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
PARP Inhibitor; small cell lung cancer; olaparib;
D O I：
10.1016/j.jtho.2019.08.489
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA15.01
引用
收藏
页码：S246 / S246
页数：1
相关论文
共 50 条
  • [1] Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer
    Farago, Anna F.
    Yeap, Beow Y.
    Stanzione, Marcello
    Hung, Yin P.
    Heist, Rebecca S.
    Marcoux, J. Paul
    Zhong, Jun
    Rangachari, Deepa
    Barbie, David A.
    Phat, Sarah
    Myers, David T.
    Morris, Robert
    Kem, Marina
    Dubash, Taronish D.
    Kennedy, Elizabeth A.
    Digumarthy, Subba R.
    Sequist, Lecia V.
    Hata, Aaron N.
    Maheswaran, Shyamala
    Haber, Daniel A.
    Lawrence, Michael S.
    Shaw, Alice T.
    Mino-Kenudson, Mari
    Dyson, Nicholas J.
    Drapkin, Benjamin J.
    CANCER DISCOVERY, 2019, 9 (10) : 1372 - 1387
  • [2] Results of stage 1 of the oparatic trial: A phase I study of olaparib in combination with temozolomide in patients with relapsed glioblastoma
    Chalmers, Anthony J.
    Jackson, Alan
    Swaisland, Helen
    Stewart, William
    Helford, Sarah E. R.
    Mollfe, L. Rhoda
    Hargrave, Darren R.
    McCormick, Alex
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Safety and efficacy of combination olaparib (O) and temozolomide (T) in small cell lung cancer (SCLC).
    Farago, Anna F.
    Drapkin, Benjamin Jacob
    Charles, Allison
    Yeap, Beow Y.
    Heist, Rebecca Suk
    Azzoli, Christopher G.
    Jackman, David Michael
    Marcoux, J. Paul
    Barbie, David Allen
    Myers, David T.
    Phat, Sarah
    Zhong, Jun
    Grinnell, Jane Bailey
    Sequist, Lecia V.
    Mino-Kenudson, Mari
    Maheswaran, Shyamala
    Haber, Daniel A.
    Hata, Aaron N.
    Dyson, Nicholas John
    Shaw, Alice Tsang
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Phase II trial of vinflunine (VFL) in sensitive and refractory relapsed small-cell lung cancer (SCLC): Updated results
    Lunin, S. D.
    Spigel, D. R.
    Hainsworth, J. D.
    Waterhouse, D. M.
    Infante, J. R.
    Yardley, D. A.
    Burris, H. A., III
    Vazquez, E. R.
    Farley, C.
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] The clinical efficacy of olaparib monotherapy or combination with ceralasertib (AZD6738) in relapsed small cell lung cancer.
    Park, Sehhoon
    Mortimer, Peter G.
    Smith, Simon
    Kim, Heejung
    Jung, Hyun Ae
    Sun, Jong-Mu
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Woong-Yang
    Lee, Se-Hoon
    Park, Keunchil
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Phase II Trial of metronomic Temozolomide and Topotecan in patients with relapsed and/or refractory Small Cell Lung Cancer.
    Bhattacharyya, Gouri Shankar
    Parikh, Purvish M.
    Biswas, Ghanashyam
    Bondarde, Shailesh A.
    Malhotra, Hemant
    Vora, Amish
    Govindbabu, K.
    Ranade, Anantbhushan A. B.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S743 - S743
  • [7] RESULTS OF THE OPARATIC TRIAL: A PHASE I DOSE ESCALATION STUDY OF OLAPARIB IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN PATIENTS WITH RELAPSED GLIOBLASTOMA (GBM)
    Chalmers, Anthony
    Cruickshank, Garth
    Dunn, Laurence
    Erridge, Sara
    Godfrey, Lisa
    Herbert, Christopher
    Jefferies, Sarah
    Lopez, Juanita
    McBain, Catherine
    Pittman, Marc
    Sleigh, Rebecca
    Watts, Colin
    Webster-Smith, Mark
    Halford, Sarah
    NEURO-ONCOLOGY, 2017, 19 : 4 - 4
  • [8] Results of the OPARATIC trial: A phase I dose escalation study of olaparib in combination with temozolomide (TMZ) in patients with relapsed glioblastoma (GBM).
    Halford, Sarah E. R.
    Cruickshank, Garth
    Dunn, Laurence
    Erridge, Sara
    Godfrey, Lisa
    Herbert, Christopher
    Jefferies, Sarah
    Lopez, Juanita Suzanne
    McBain, Catherine
    Pittman, Marc
    Sleigh, Rebecca
    Watts, Colin
    Webster-Smith, Mark F.
    Chalmers, Anthony J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Phase II Study of Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer
    Pietanza, M. Catherine
    Travis, William D.
    Chan, Timothy A.
    Ginsberg, Michelle S.
    Kris, Andrei Holodny Mark G.
    Krug, Lee M.
    PANCREAS, 2010, 39 (02) : 279 - 279
  • [10] Phase II study of temozolomide for relapsed sensitive or refractory small cell lung cancer
    Pietanza, Maria Catherine
    Pereira, Leanne
    Dunne, Meghan
    Travis, William D.
    Chan, Timothy A.
    Ginsberg, Michelle S.
    Holodny, Andrei
    Kris, Mark G.
    Krug, Lee M.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S819 - S820
12345